W3B-22914-96735
3 vaccinations
2 coded responses
33 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 809 / CO
- Registered
- 2021-04-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
89X-20778-12734
Child or adolescent in my care · Male · 2021-12-13
Q2F-18746-93584
Child or adolescent in my care · Female · 2021-12-13
Timeline
-
2021-04-05
Registered in v-safe
-
2021-04-05
Dose 1 — Pfizer-BioNTech
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-19
-
2021-04-26
Dose 2 — Pfizer-BioNTech
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-01
- 2021-05-02
- 2021-05-03
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-06-07
- 2021-07-26
- 2021-10-25
-
2021-12-11
Dose 3 — Pfizer-BioNTech
-
2021-12-13
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Joint pains, Muscle or body achesAdult check-in
- 2021-12-15
- 2021-12-18
-
2022-01-01
Survey response — day 21, dose 3MedDRA: Cough, Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: A mild cold with a cough. Have not tested for covid.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-10
- 2022-01-15
- 2022-01-22
- 2022-03-14
- 2022-06-13
-
2022-12-14
Survey response — 12 months, dose 3MedDRA: Arthropathy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Problems with jointsMedDRA releases: 2024-11 · check-in free text available
-
2022-12-14
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-12-15
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-05 | Pfizer-BioNTech | |
| 2 | 2021-04-26 | Pfizer-BioNTech | |
| 3 | 2021-12-11 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-14 | Successful 2022-12-15 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 10 — day 21, dose 3
Symptoms: A mild cold with a cough. Have not tested for covid.
Release 12 — 12 months, dose 3
Symptoms: Problems with joints
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthropathy | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release